Testing effectiveness (Phase 2)Study completedNCT02387606
What this trial is testing
Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection.
Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Sciences Ireland UC 66